Researchers find experimental drug can help fight debilitating side effect of ovarian cancer
11/17/2015
UCLA team finds new way to reduce painful, common condition called ascitesWomen who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen.
Changes in brain associated with peripheral nerve issues caused by cancer therapy
11/17/2015
Researchers at Indiana University School of Medicine have identified physiological changes in the brain that appear to be associated with peripheral nerve-related symptoms caused by chemotherapy.
Changes in metabolites can regulate earliest stages of development
11/17/2015
Findings may offer insights into a variety of disorders and advance embryonic stem cell research.
Thrombosis during sepsis is a consequence of protective host immune responses
11/16/2015
Researchers from the University of Birmingham have, for the first time, identified how Salmonella infections that have spread to our blood and organs can lead to life-threatening thrombosis.
Early cancer diagnosis balancing act for GPs
11/16/2015
General practitioners face a balancing act when trying to rule out an early diagnosis of cancer in their patients, while new tools to assess risk need more research to determine their usefulness...
Telehealth safely delivers chemo to rural patients
11/16/2015
High-quality cancer care can be safely provided at rural centres via a telehealth approach, using supervision by urban-based doctors, new research published in the Medical Journal of Australia...
FDA approves modified antihemophilic factor for hemophilia A
11/16/2015
The U.S. Food and Drug Administration has approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.
FDA approves new pill to treat certain patients with non-small cell lung cancer
11/16/2015
The U.S. Food and Drug Administration has granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC).
New Modeling Analysis Shows Screening for Cervical Cancer with Pap+HPV Together™ Could Provide Better Clinical and Economic Outcomes than Screening with HPV Alone*: Co-testing could prevent...
Scientists discover how to sensitize drug-resistant human glioblastoma cells to chemotherapy
11/16/2015
Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.